Cargando…
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis
The current in vivo models for the utility and discovery of new potential anti-leishmanial drugs targeting Cutaneous Leishmaniasis (CL) differ vastly in their immunological responses to the disease and clinical presentation of symptoms. Animal models that show similarities to the human form of CL af...
Autores principales: | Mears, Emily Rose, Modabber, Farrokh, Don, Robert, Johnson, George E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559374/ https://www.ncbi.nlm.nih.gov/pubmed/26334763 http://dx.doi.org/10.1371/journal.pntd.0003889 |
Ejemplares similares
-
Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and Development
por: Seifert, Karin
Publicado: (2011) -
Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect
por: Bashir, Sidra, et al.
Publicado: (2023) -
Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis
por: Olliaro, Piero, et al.
Publicado: (2013) -
Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
por: CHARLTON, REBECCA L., et al.
Publicado: (2018) -
Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis
por: Ghalib, Hashim, et al.
Publicado: (2007)